Published in Biotech Business Week, November 7th, 2005
"We've now completed the upgrade of our infrastructure to include the new Affymetrix 7G and MegAllele scanners, allowing us to process the newly released Affymetrix GeneChip Exon Arrays, the Affymetrix GeneChip 500K Mapping Array Set, and the MegAllele DME-T assay developed by ParAllele," said Dr. Tom Goralski, Expression Analysis' laboratory director. "These advancements give investigators additional tools to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.